Market cap data unavailable. We couldn't positively verify this ticker's market cap is under $500M. Verify independently before trading.
Healthy Extracts Inc.
- Market Cap
- Unavailable
- Price
- $1.35
- % Change (Daily % change from the live per-ticker quote feed.)
- 0.00%
- Volume
- 200
About
Healthy Extracts Inc., through its various divisions, specializes in the global and domestic research, development, and sale of natural botanical products. Its portfolio encompasses dietary supplements crafted for cardiovascular wellness, alongside KETONOMICS-branded neuro-enhancers aimed at boosting cognitive functions like memory, mental acuity, concentration, and neural energy. The company further supplies encapsulated bergamot products, available under distinct labels such as BergaMet Pro+, BergaMet Mega+O, BergaMet HERHEART, BergaMet Cholesterol Command, and BergaMet SPORTSHEART. These bergamot offerings are distributed via its online platform and various other channels. Established in 2014 and based in Littleton, Colorado, the company was previously known as Grey Cloak Tech Inc. until its name change in October 2020.
Quick stats
Shares outstanding—
Computed float826.2K
Float / sharesUnknown
Key info
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001630176
AI Summary
AI-generated1/5
majorbullishearnings
Healthy Extracts Q2 2026 Net Revenue Up 113% to Record $2.1 Million, Driving Adj. EBITDA of $290,000 or $0.02 per Share
Healthy Extracts reported Q2 net revenue of $2.1 million, up 113% year-over-year, driven by the integration of Gummy USA and the acquisition of Imaraïs Beauty.
Adjusted EBITDA turned positive to $290,000 with gross margins expanding significantly to 70.3%, although the company recorded a GAAP net loss of $129,000 due to higher operating expenses.
Management expressed confidence in achieving an annualized net revenue run rate exceeding $20 million by year-end, supported by new B2B contracts and expanded retail distribution.
Red flags
- GAAP net loss of $129,000 compared to net income of $67,000 in the prior year
- Cash balance of $190,000 is insufficient to cover quarterly operating expenses of $1.5 million, indicating liquidity risk